N4 -Tetradentate Chelators Efficiently Regulate Copper Homeostasis and Prevent ROS Production Induced by Copper-Amyloid-β1-16.

The disruption of copper homeostasis and the oxidative stress induced by Cu-amyloids are crucial features of Alzheimer's disease pathology. The copper specific N4 -tetradendate ligands TDMQ20 and 1 are able to fully inhibit in vitro the aerobic oxidation of ascorbate induced by Cu-Aβ1-16 , even in the presence of 100 molar equivalents of ZnII with respect to CuII , whereas other ligands with N2 O2 or N3 O2 coordination spheres failed to do so. This essential result indicates that, in addition to metal selectivity, the coordination sphere of copper chelators should exhibit a N4 -tetradendate motif to be able to reduce an oxidative stress in the zinc-rich physiological environment of brain. The N4 -scaffolds of these two aminoquinoline-based ligands, TDMQ20 or 1, suitable for a square-planar coordination of copper(II), allowed them to enhance both the selectivity for copper and the ability to reduce the oxidative stress induced by copper-amyloid in a zinc-rich environment.

[1]  M. Nguyen,et al.  Preparation of Tetradentate Copper Chelators as Potential Anti‐Alzheimer Agents , 2018, ChemMedChem.

[2]  C. Hureau,et al.  Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level , 2017, Dalton transactions.

[3]  M. Kawahara,et al.  Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases. , 2017, Metallomics : integrated biometal science.

[4]  M. Nguyen,et al.  Structures of the Copper and Zinc Complexes of PBT2, a Chelating Agent Evaluated as Potential Drug for Neurodegenerative Diseases , 2017 .

[5]  S. Sajikumar,et al.  Chelation of hippocampal zinc enhances long‐term potentiation and synaptic tagging/capture in CA1 pyramidal neurons of aged rats: implications to aging and memory , 2016, Aging cell.

[6]  P. Faller,et al.  How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study , 2016, Dalton transactions.

[7]  M. Nguyen,et al.  Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand. , 2015, Chemistry.

[8]  D. Testemale,et al.  Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand. , 2015, Metallomics : integrated biometal science.

[9]  M. Nguyen,et al.  Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease. , 2015, Accounts of chemical research.

[10]  M. Nguyen,et al.  The Necessity of Having a Tetradentate Ligand to Extract Copper(II) Ions from Amyloids , 2014, ChemistryOpen.

[11]  A. Bush,et al.  Biological metals and metal-targeting compounds in major neurodegenerative diseases. , 2014, Chemical Society reviews.

[12]  A. Takeda,et al.  Intracellular Zn2+ signaling in cognition , 2014, Journal of neuroscience research.

[13]  M. Nguyen,et al.  Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease. , 2014, Chemistry.

[14]  M. Telpoukhovskaia,et al.  Werner coordination chemistry and neurodegeneration. , 2013, Chemical Society reviews.

[15]  O. Proux,et al.  Zn impacts Cu coordination to amyloid-β, the Alzheimer's peptide, but not the ROS production and the associated cell toxicity. , 2013, Chemical communications.

[16]  R. Mains,et al.  Copper signaling in the mammalian nervous system: Synaptic effects , 2012, Journal of neuroscience research.

[17]  P. Faller,et al.  A bioinorganic view of Alzheimer's disease: when misplaced metal ions (re)direct the electrons to the wrong target. , 2012, Chemistry.

[18]  A. Bush,et al.  The Neurophysiology and Pathology of Brain Zinc , 2011, The Journal of Neuroscience.

[19]  K. Blennow,et al.  PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. , 2010, Journal of Alzheimer's disease : JAD.

[20]  K. Franz,et al.  Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease. , 2010, Dalton transactions.

[21]  D. Andersson,et al.  Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+ , 2009, Proceedings of the National Academy of Sciences.

[22]  J. Huidobro-Toro,et al.  Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy. , 2007, Neurotoxicology.

[23]  M. Selig,et al.  Clioquinol-Zinc Chelate: A Candidate Causative Agent of Subacute Myelo-Optic Neuropathy , 1998, Molecular medicine.

[24]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[25]  E. P. Huang,et al.  Metal ions and synaptic transmission: think zinc. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. D. Marco,et al.  Reconstitution of Ceruloplasmin by the Cu(I)-Glutathione Complex , 1996, The Journal of Biological Chemistry.

[27]  G. Buettner,et al.  Ascorbate free radical as a marker of oxidative stress: an EPR study. , 1993, Free radical biology & medicine.

[28]  A. Desideri,et al.  Reconstitution of Cu,Zn-superoxide dismutase by the Cu(I).glutathione complex. , 1990, The Journal of biological chemistry.

[29]  M. Ciriolo,et al.  The role of glutathione in copper metabolism and toxicity. , 1989, The Journal of biological chemistry.

[30]  J. Phillips The Reactions Of 8-Quinolinol , 1956 .